Analysts Anticipate FYX Will Reach $124

An ETF Channel analysis projects a 15.01% upside for the First Trust Small Cap Core AlphaDEX Fund ETF (FYX), with an implied analyst target price of $123.78, derived from the weighted average 12-month forward targets of its underlying holdings. This outlook is supported by significant potential gains in key constituents such as Sprinklr Inc (CXM), Diebold Nixdorf Inc (DBD), and Cimpress PLC (CMPR), which show individual upsides of 34.04%, 32.47%, and 23.82% respectively, though the report advises further scrutiny into the justification of these analyst projections.

Analysis

An ETF Channel analysis indicates a 15.01% implied upside for the First Trust Small Cap Core AlphaDEX Fund ETF (FYX), projecting a 12-month target price of $123.78 from its recent trading price of $107.62. This moderately positive outlook is derived from the weighted average of analyst 12-month forward target prices for its underlying holdings. The general sentiment surrounding this projection is moderately positive, though tempered by uncertainty regarding its justification.

Significant contributors to this projected upside include Sprinklr Inc (CXM), Diebold Nixdorf Inc (DBD), and Cimpress PLC (CMPR). CXM shows a substantial 34.04% upside to an average analyst target of $10.10, while DBD has a 32.47% potential gain to $75.67, and CMPR suggests a 23.82% increase to $77.50. These individual stock targets underpin the overall ETF's positive forecast, reflecting underlying company fundamentals.

However, the analysis introduces a note of uncertainty, questioning the justification and timeliness of these analyst targets. Investors are prompted to conduct further research to ascertain if these projections are supported by current company and industry developments or if they represent outdated views. This highlights the importance of scrutinizing analyst estimates for their relevance and potential impact on investor sentiment and positioning.

Key Decisions for Investors

• Investors should conduct thorough due diligence on the fundamental drivers and recent developments of key underlying holdings like CXM, DBD, and CMPR to validate the analyst target prices.